| NCT ID | NCT05646485 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Texas Southwestern Medical Center |
| Condition | Bladder Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2023-05-05 |
| Primary Completion | 2027-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,000 participants in total. It began in 2023-05-05 with a primary completion date of 2027-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
There is currently no accepted screening strategy for patients at high risk of developing bladder cancer. This study will ask patients to complete a urine test every 6 months for 2 years to help assess if routine screening helps finding bladder cancer at an earlier stage.
Eligibility Criteria
Inclusion Criteria: * Age ≥ 50 * Smoking: ≥15 pack-year smoking history * Occupation:≥ 15 years of occupational exposures including: textile worker, painter, dry cleaners Exclusion Criteria: * Prior history of bladder, kidney, or prostate cancer * Prior evaluation of micro or gross hematuria within the last 2 years * Do not provide informed consent
Contact & Investigator
Yair Lotan, MD
PRINCIPAL INVESTIGATOR
University of Texas Southwestern Medical Center
Frequently Asked Questions
Who can join the NCT05646485 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, studying Bladder Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05646485 currently recruiting?
Yes, NCT05646485 is actively recruiting participants. Contact the research team at yair.lotan@UTsouthwestern.edu for enrollment information.
Where is the NCT05646485 trial being conducted?
This trial is being conducted at Dallas, United States.
Who is sponsoring the NCT05646485 clinical trial?
NCT05646485 is sponsored by University of Texas Southwestern Medical Center. The principal investigator is Yair Lotan, MD at University of Texas Southwestern Medical Center. The trial plans to enroll 1,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.